Concepedia

Publication | Open Access

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

DOIFull Paper Access

96

Citations

16

References

2012

Year

Toshihiko Doi, Atsushi Ohtsu, Takayuki Yoshino, Narikazu Boku, Yusuke Onozawa, Akira Fukutomi, Shuichi Hironaka, Wasaburo Koizumi, Takeshi Sasaki
British Journal of Cancer

Abstract

TAS-102 at 70 mg m(-2) per day was tolerated in Japanese patients with advanced solid tumours. Phase II studies are ongoing in patients with colorectal cancer.

References

YearCitations

Page 1